CN101773581A - Medicine for treating female genitourinary system inflammation - Google Patents
Medicine for treating female genitourinary system inflammation Download PDFInfo
- Publication number
- CN101773581A CN101773581A CN200910010122A CN200910010122A CN101773581A CN 101773581 A CN101773581 A CN 101773581A CN 200910010122 A CN200910010122 A CN 200910010122A CN 200910010122 A CN200910010122 A CN 200910010122A CN 101773581 A CN101773581 A CN 101773581A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine
- genitourinary system
- system inflammation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 26
- 206010061218 Inflammation Diseases 0.000 title claims abstract description 14
- 230000004054 inflammatory process Effects 0.000 title claims abstract description 14
- 210000002229 urogenital system Anatomy 0.000 title claims abstract description 11
- 229940079593 drug Drugs 0.000 title claims abstract description 7
- 210000000582 semen Anatomy 0.000 claims abstract description 6
- 241000722953 Akebia Species 0.000 claims abstract description 3
- 241001071795 Gentiana Species 0.000 claims abstract description 3
- 241000255791 Bombyx Species 0.000 claims description 5
- 241000283956 Manis Species 0.000 claims description 5
- 241001180876 Saposhnikovia Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 5
- 206010046798 Uterine leiomyoma Diseases 0.000 abstract description 4
- 208000025661 ovarian cyst Diseases 0.000 abstract description 4
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 abstract description 3
- 208000008350 Pruritus Vulvae Diseases 0.000 abstract description 3
- 208000006374 Uterine Cervicitis Diseases 0.000 abstract description 3
- 206010046914 Vaginal infection Diseases 0.000 abstract description 3
- 201000008100 Vaginitis Diseases 0.000 abstract description 3
- 206010056530 Vulvovaginal pruritus Diseases 0.000 abstract description 3
- 230000001154 acute effect Effects 0.000 abstract description 3
- 206010008323 cervicitis Diseases 0.000 abstract description 3
- 230000001684 chronic effect Effects 0.000 abstract description 3
- 230000003628 erosive effect Effects 0.000 abstract description 3
- 201000009273 Endometriosis Diseases 0.000 abstract description 2
- 206010046814 Uterine prolapse Diseases 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000035606 childbirth Effects 0.000 abstract description 2
- 238000002474 experimental method Methods 0.000 abstract description 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 241001660870 Cyrtomium Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 241000951473 Schizonepeta Species 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 206010020718 hyperplasia Diseases 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 210000005075 mammary gland Anatomy 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 239000000843 powder Substances 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000003679 cervix uteri Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- -1 azoles sodium chloride Chemical class 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 208000030270 breast disease Diseases 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine, in particular to a medicine for treating female genitourinary system inflammation. The medicine is prepared from the following raw material medicines in parts by weight: 25-35 parts of gentian, 8-12 parts of rhizoma alismatis, 8-12 parts of cortex dictamni, 8-12 parts of coptis chinensis, 25-32 parts of radix sophorae flavescentis, 7-13 parts of akebia stem, 8-12 parts of cyrtomium rhizome, 7-14 parts of schizonepeta, 12-20 parts of radix bupleuri, 12-18 parts of semen plantaginis, 12-18 parts of golden cypress, 7-12 parts of stiff silkworm, 9-12 parts of pangolin, 12-18 parts of salvia miltiorrhiza, 8-15 parts of liquorice, 12-20 parts of angelica sinensis, 12-20 parts of radix sileris and 8-15 parts of fructus cnidii. The invention has the beneficial effects that: a large number of clinical experiments prove that the medicine has obvious curative effects on gynecological genitourinary system inflammation, including acute and chronic vaginitis, pruritus vulvae, leucorrhea increase, peculiar smell, cervicitis, cervical erosion, pelvic inflammation, ovarian cyst and other diseases, and also has certain curative effects on hyperplasia of mammary glands, uterine prolapse, hysteromyoma, endometriosis and recovery treatment after childbirth.
Description
Affiliated field
The present invention relates to a kind of medicine, promptly a kind of medicine for the treatment of female genitourinary system inflammation.
Background technology
Gynecological's genitourinary system inflammation comprises diseases such as acute and chronic vaginitis, pruritus vulvae, leucorrhoea grow in quantity, abnormal flavour, cervicitis, cervical erosion, pelvic inflammatory disease, ovarian cyst, is a class commonly encountered diseases, frequently-occurring disease.The patient is very painful, and is difficult to cure.The at present clinical antibiotic antiinflammatory of adopting, effect is undesirable, and has certain side effect more.
Summary of the invention
The objective of the invention is to propose a kind of female genitourinary system inflammation to be had significant curative effect, toxic and side effects is low, and is easy to use, medicine with low cost.
Above-mentioned purpose is realized by following technical scheme: develop a kind of medicine for the treatment of female genitourinary system inflammation, be characterized in: said medicine is to be made by following crude drug by weight: Radix Gentianae 25-35 part, Rhizoma Alismatis 8-12 part, Cortex Dictamni 8-12 part, Rhizoma Coptidis 8-12 part, Radix Sophorae Flavescentis 25-32 part, Caulis Akebiae 7-13 part, Rhizoma Osmundae 8-12 part, Herba Schizonepetae 7-14 part, Radix Bupleuri 12-20 part, Semen Plantaginis 12-18 part, Cortex Phellodendri 12-18 part, Bombyx Batryticatus 7-12 part, Squama Manis 9-12 part, Radix Salviae Miltiorrhizae 12-18 part, Radix Glycyrrhizae 8-15 part, Radix Angelicae Sinensis 12-20 part, Radix Saposhnikoviae 12-20 part, Fructus Cnidii 8-15 part.
Said medicine is to be made by following crude drug by weight: 30 parts of Radix Gentianaes, 10 parts of Rhizoma Alismatis, 10 parts of Cortex Dictamni, 10 parts of Rhizoma Coptidis, 30 parts of Radix Sophorae Flavescentiss, 10 parts of Caulis Akebiaes, 10 parts of Rhizoma Osmundae, 10 parts of Herba Schizonepetae, 15 parts of Radix Bupleuri, 15 parts of Semen Plantaginis 15 Cortex Phellodendris, 10 parts of Bombyx Batryticatus, 10 parts of Squama Maniss, 15 parts of Radix Salviae Miltiorrhizaes, 10 parts in Radix Glycyrrhizae, 15 parts of Radix Angelicae Sinensis, 15 parts of Radix Saposhnikoviaes, 10 parts of Fructus Cnidiis.
The invention has the beneficial effects as follows: through a large amount of clinical trial certificates, this medicine is to gynecological's genitourinary system inflammation, comprise that diseases such as acute and chronic vaginitis, pruritus vulvae, leucorrhoea grow in quantity, abnormal flavour, cervicitis, cervical erosion, pelvic inflammatory disease, ovarian cyst have significant curative effect, the restorative treatment of cyclomastopathy, uterine prolapse, hysteromyoma, endometriosis and childbirth postoperative is also had certain curative effect.And have short treating period, expense is low, characteristics such as taking convenience.Through toxicological experiment and clinical observation, do not find toxic and side effects.Thereby for removing patient's slight illness, the quality of life of improving the women has brought Gospel.
The specific embodiment
First kind of embodiment: choose crude drug Radix Gentianae 30g, Rhizoma Alismatis 10g, Cortex Dictamni 10g by standard, Rhizoma Coptidis 10g, Radix Sophorae Flavescentis 30g, Caulis Akebiae 10g, Rhizoma Osmundae 10g, Herba Schizonepetae 10g, Radix Bupleuri 15g, Semen Plantaginis 15g, Cortex Phellodendri 15g, Bombyx Batryticatus 10g, Squama Manis 10g, Radix Salviae Miltiorrhizae 15g, Radix Glycyrrhizae 10g, Radix Angelicae Sinensis 15g, Radix Saposhnikoviae 15g, Fructus Cnidii 10g.
Capsular making step:
1, carries out the quality screening in strict accordance with ratio requirement and consumption and be used as medicine;
2, with clear water it is cleaned up, reach no foreign body, free from admixture;
3, pulverize or be ground into fine grinding after the oven dry, add and hold up water (to comfort health azoles 0.20 gram greatly; Sodium chloride normal saline 0,9 gram 100ML/5 bottle)
4, blended medicament is dried, be as the criterion with little brown;
5, medicated powder is incapsulated mould and carry out fill, drop into automatic assembly line and pack.
The watered pill is made the same, adds the liquid that forms pill and gets final product for holding up health azoles sodium chloride liquid.
To be divided into be three courses of treatment in treatment, and be 15 days each course of treatment, and every day three times is oral, and one after each meal, must be carried out in strict accordance with operation instruction in therapeutic process by each 4.
Taboo: pungent food
Clinical observation:
1, suffer from bacterial vaginitis disease, the patient of cervix uteri inflammation took in 3-5 days, and leucorrhea reduces, and pudendum is pruritus no longer, and pudendum is red and swollen to disappear; The patient of leucorrhoea grow in quantity, as the heavy patient of trichomonal vaginitis disease and fungal infection, it is many and rare to occur leucorrhea in 3 days, occurs less and thickness later in three days, and color is progressively recovered normally, frequent micturition, short urination, dysurea begins to be eased or transference cure.
2, treatment is 3 days-5 days, suffers from the patient of cyclomastopathy, ovarian cyst, and feels pain disappears, and breast disease cover district feels the phenomenon of obvious wriggling, and dermal sensation is no longer dry and astringent, and is pliable and tough smooth.
3, the patient of treatment more than 6 days feel waist no longer acid expand, extremity obviously have hectic fever, no longer ice-cold fear of cold, cardiopalmus, agitation, phenomenon such as uncomfortable in chest.The migraine that some patient merges appearance is also alleviated accordingly.
4, the serious patient of cervix uteri inflammation, as: occur having in the leucorrhea blood or yellow to increase, the serious patient of trichomonal vaginitis disease can add 0.5% soda water washing vagina or add soda powder with this medicated powder that a little becomes mixture with the medicated powder in 20 of this capsules, the rayon balls of getting 3 centimetres of diameters then wraps up with gauze, the lower end is a cotton rope, stay outside vaginal orifice, so that replacement medicine, again the medicated powder mixture is bonded on the gauze ball, insert intravaginal up to the cervix uteri place, once a day, can in 7-10 days, cure.The man can be during accidental resemblance with medicated powder and soda powder in 20 capsules a little mix the cleaning genitals with 100ML water and get final product for 1-3 time.
5, treat the course of treatment course of treatment to two, patient's hypertrophy position, cyst position fundamental symptoms disappear, and be the steadiness treatment the 3rd course of treatment; Hysteromyoma also has comparatively significantly and dwindles, but because the Uterine myomas gene is main relevant with hormone secretion, so fairy maiden's pellet mainly plays the concurrent inflammation of elimination, activating blood circulation to dissipate blood stasis, the auxiliary therapy of elimination distending pain; In addition, menstruation flood fore udder, lower abdomen be distending pain no longer, and menstrual blood loss can recover normally, is exactly that the described pain of the traditional Chinese medical science is then obstructed, and general rule is bitterly Coryza Treated by Syndrome Differentiation mechanism not.
Above clinical treatment observation result is as meeting or near meeting this clinical manifestation, then being effectively to cure or produce effects, if be difficult effect then for invalid.
Claims (2)
1. medicine for the treatment of female genitourinary system inflammation, it is characterized in that: said medicine is to be made by following crude drug by weight: Radix Gentianae 25-35 part, Rhizoma Alismatis 8-12 part, Cortex Dictamni 8-12 part, Rhizoma Coptidis 8-12 part, Radix Sophorae Flavescentis 25-32 part, Caulis Akebiae 7-13 part, Rhizoma Osmundae 8-12 part, Herba Schizonepetae 7-14 part, Radix Bupleuri 12-20 part, Semen Plantaginis 12-18 part, Cortex Phellodendri 12-18 part, Bombyx Batryticatus 7-12 part, Squama Manis 9---12 parts, Radix Salviae Miltiorrhizae 12-18 part, Radix Glycyrrhizae 8-15 part, Radix Angelicae Sinensis 12-20 part, Radix Saposhnikoviae 12-20 part, Fructus Cnidii 8-15 part.
2. the medicine of treatment female genitourinary system inflammation according to claim 1 is characterized in that: said medicine is to be made by following crude drug by weight: 30 parts of Radix Gentianaes, 10 parts of Rhizoma Alismatis, 10 parts of Cortex Dictamni, 10 parts of Rhizoma Coptidis, 30 parts of Radix Sophorae Flavescentiss, 10 parts of Caulis Akebiaes, 10 parts of Rhizoma Osmundae, 10 parts of Herba Schizonepetae, 15 parts of Radix Bupleuri, 15 parts of Semen Plantaginis 15 Cortex Phellodendris, 10 parts of Bombyx Batryticatus, 10 parts of Squama Maniss, 15 parts of Radix Salviae Miltiorrhizaes, 10 parts in Radix Glycyrrhizae, 15 parts of Radix Angelicae Sinensis, 15 parts of Radix Saposhnikoviaes, 10 parts of Fructus Cnidiis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910010122A CN101773581A (en) | 2009-01-14 | 2009-01-14 | Medicine for treating female genitourinary system inflammation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910010122A CN101773581A (en) | 2009-01-14 | 2009-01-14 | Medicine for treating female genitourinary system inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101773581A true CN101773581A (en) | 2010-07-14 |
Family
ID=42510256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910010122A Pending CN101773581A (en) | 2009-01-14 | 2009-01-14 | Medicine for treating female genitourinary system inflammation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101773581A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103989786A (en) * | 2014-05-27 | 2014-08-20 | 刘云平 | Traditional Chinese medicine for treating pruritus vulvae |
| CN105125812A (en) * | 2015-09-30 | 2015-12-09 | 赵建华 | Nursing disinfectant used in obstetrics and gynecology department and preparation method thereof |
-
2009
- 2009-01-14 CN CN200910010122A patent/CN101773581A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103989786A (en) * | 2014-05-27 | 2014-08-20 | 刘云平 | Traditional Chinese medicine for treating pruritus vulvae |
| CN103989786B (en) * | 2014-05-27 | 2015-08-19 | 刘云平 | A kind of Chinese medicine for the treatment of pruritus vulvae |
| CN105125812A (en) * | 2015-09-30 | 2015-12-09 | 赵建华 | Nursing disinfectant used in obstetrics and gynecology department and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104998160A (en) | Gynecological lotion | |
| CN103599472B (en) | A kind of Chinese medicine composition being used for the treatment of prostatic hyperplasia | |
| CN101181468A (en) | Chinese medicine composition orally taken for curing cystitis | |
| CN103099993A (en) | Traditional Chinese medicine combination for treating uterine prolapse | |
| CN101773581A (en) | Medicine for treating female genitourinary system inflammation | |
| CN102727725B (en) | Pharmaceutical composition for promoting healing of postoperative wound | |
| CN105267472A (en) | Traditional Chinese medicine medicament for treating gynecological diseases and applications thereof | |
| CN104740536A (en) | Pharmaceutical composition for treating endometriosis (EMT) and adenomyosis (AM) and preparation method and use thereof | |
| CN103655845A (en) | Traditional Chinese medicine composition for treating uterine prolapse | |
| CN103550708B (en) | Chinese herbal compound for treating dysmenorrheal | |
| CN104840699A (en) | Medicine composition for treating chronic pelvic inflammation | |
| CN102114221B (en) | Medicine for treating female infertility | |
| CN105311594A (en) | Chilblain treatment liniment | |
| CN104606368A (en) | Traditional Chinese medicine composition for treating threatened abortion in first trimester of pregnancy | |
| CN101653572B (en) | Traditional Chinese medicine coloclysis composition for effectively treating pelvic inflammatory disease | |
| CN102389557B (en) | Chinese medicinal composition and Chinese medicinal ball for treating uterine cancer and application thereof | |
| CN103611037B (en) | A kind of Chinese medicine fuming-lotion for the treatment of senile vaginitis | |
| CN102526390A (en) | Chinese medicine preparation for treating gynecological vaginitis | |
| CN101371912A (en) | Chinese medicine oral decoction for treating dysmenorrhea | |
| CN105998421A (en) | Traditional Chinese medicine composition for treating hysteromyoma | |
| CN105456922A (en) | Traditional Chinese medicinal pills for treating gynaecopathia | |
| CN103127352B (en) | Chinese medicine composition for treating blood stasis type irregular menstruation | |
| CN103585572B (en) | Oral medicine for treating endometriosis | |
| CN104257974A (en) | Traditional Chinese medicine for treating exuberant heat-toxicity type acute pelvic inflammatory disease | |
| CN104352950A (en) | Traditional Chinese medicine composition for treating gynecological inflammation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20100714 |